Article

Clinicians should consider seasonal effects on IOP

Kyoto, Japan?Seasonal variation in IOP is important to take into account when evaluating those patients with glaucoma and particularly those with steroid-induced ocular hypertension, according to Kazuhiko Mori, MD, PhD.

Dr. Mori presented results from a retrospective, observational, case control study of 43,379 cumulative patients seen in the glaucoma service at Kyoto Prefectural University of Medicine Hospital, Kyoto, Japan, over a 10-year period from September 1995 to August 2004.

The subjects were divided into five categories based on diagnosis:

However, the most drastic seasonal difference was seen in eyes with steroid-induced ocular hypertension. In that subgroup, there was a 5.1 mm Hg difference in IOP comparing summer and winter. For eyes with POAG, CACG, NTG, and SG, the mean seasonal difference in IOP was 1.5, 1.3, 0.9, and 1.8 mm Hg, respectively.

"This is a retrospective study, and the patients were using medications that might have influenced the results and caused an underestimation of the seasonal variation. However, even if the treatment of glaucoma is changed according to the patients' condition, these results suggest that the seasonal variation of IOP should be taken into consideration when treating glaucoma patients," said Dr. Mori, glaucoma service, Kyoto Prefectural University of Medicine.

Dr. Mori explained the study was undertaken based on anecdotal observations of some cases where IOP rose markedly in winter.

"Previous statistical reports have shown that seasonal variation in IOP is relatively small, but we conducted this study because our experience showed that was not always the case," he said.

Seasonal IOP differences

For the entire group, there was a 1.3 mm Hg difference between the mean IOP in winter (17 mm Hg) and summer (15.7 mm Hg), he said.

Dr. Mori noted that the causes for seasonal variation in IOP are unclear. Considering that other studies that have reported a relatively larger magnitude of seasonal variation in IOP were conducted in geographic locations where there is a greater than 15° seasonal variation in temperature suggests cold weather may play a role.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.